Net Income

Facing delisting, Chinese e-mobility firm EZGO enacts a drastic 1-for-150 reverse split. We explore what this means for the company and its investors.

A new report ranks Changi Airport among the world's top carbon emitters, challenging Singapore's sustainable hub ambitions amid rising global pressure.

Glucotrack seeks FDA trial approval for its revolutionary 3-year implantable glucose monitor, racing against financial clocks to change diabetes care.

Amid major Medicare policy shifts, Nuo Therapeutics reports a 169% revenue surge, positioning its Aurix wound care system as a key market disruptor.

Nubank's AI-first strategy drives record revenue and profitability in Mexico, but rising delinquencies test its advanced risk management models.

A Houston firm is set to make waves with a rare Modigliani drawing and a private Dalí painting, complete with personal letters from the artist.

Westaim posted a $33.4M Q1 loss, but strong early sales from its new annuity product suggest a long-term strategic transformation is taking root.

The Solana treasury firm reported a massive GAAP loss due to SOL's price drop, but it also secured new debt, bought back shares, and pushed into new markets.

Out of 600+ plans, Alignment Health is one of just four to earn a top award for medication quality. Here's what that means for seniors and the industry.

Edesa Biotech pushes its pipeline forward with a new vitiligo trial and promising ARDS data, but rising R&D costs highlight the high stakes of innovation.

The chip equipment giant posts record Q2 revenue and profit, driven by surging AI demand, and unveils major partnerships to accelerate future tech.

The biotech firm is set to launch its first commercial products, using an innovative strategy to tackle long-neglected markets in women's healthcare.

As the healthcare industry bleeds talent, PruittHealth's fifth consecutive 'Great Place to Work' award reveals its culture-first strategy for retention and growth.

A novel device that treats hypertension from outside the artery shows early promise, challenging market leaders and offering new hope for millions.

A local partnership's stunning success in reducing infant mortality is gaining national attention, offering a blueprint for how to save mothers and babies.

Soaring costs and long waits at home are driving thousands of Europeans to Albania for dental implants, where clinics offer top-tier care for less.

As GAAD marks 15 years, Level Access democratizes training to bridge the digital divide, proving accessibility is no longer just a cause, but a revenue driver.

A new prop firm says its capital-backed framework will ensure sustainable trader payouts, aiming to bring a new standard of transparency to the industry.

The Nexus Forum launches to connect China's booming biotech scene with global pharma, capitalizing on a major shift in worldwide drug discovery and deal-making.

NFL legend Brett Favre reports gains from an experimental Parkinson's drug, but what does the science say about this potential breakthrough treatment?